iVAC-CLL01

patient-individualized peptide vaccination

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for iVAC-CLL01, covering 2022-11-28 to 2022-11-28. Get the full timeline:

Most recent: Clinical Trial Update: iVAC-CLL01: Patient-individualized Peptide Vaccination After First Line Therapy of CLL [Phase 2]